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Thymoquinone (TQ) is a bioactive component found in many medicinal herbs. In this study, we report the smooth and cardiac
muscle relaxant activities of this compound. TQ concentration dependently suppressed spontaneously contracting rabbit jejunum
while also relaxed high K+ -(80 mM) induced contractions in jejunum and guinea-pig ileum, indicating activity at voltage-operated
Ca++ channels (VOCC). Further, TQ displaced Ca++ concentration-response curves, obtained in a Ca++ -free environment, to the
right, showing blockade of VOCC. Similar activity was observed with verapamil, a standard VOCC blocker. TQ also exhibited
nonadrenergic relaxation of agonist-induced contractions in guinea-pig trachea. When tested in fluo-4-loaded mouse lung
slices, TQ inhibited ACh-induced airway narrowing and Ca++ signalling in airway smooth muscle cells. In endothelium-intact
and endothelium-denuded rat aorta, TQ inhibited high K+ -induced contractions at significantly lower concentrations than
phenylephrine-(PE-) (1 microM) induced contractions. Relaxation of PE-induced contractions was resistant to blockade by LNAME and atropine. In guinea-pig atria, TQ showed noncholinergic relaxation of atrial force and rate of contractions. These data
suggest smooth and cardiac muscle relaxant activity of TQ possibly mediated, in part, via blockade of VOCC. The results also
justify the use of TQ containing plants in related health disorders like colic, diarrhoea, cough, and asthma.

1. Introduction
Thymoquinone (IUPAC name: 2-Isopropyl-5-methylbenzo1,4-quinone) ; TQ is an aromatic ketone (Figure 1) found
in many medicinal plants. It is known to be an active phytochemical constituent in seeds of Nigella sativa or black cumin
[1], whole plant of Satureja Montana or savory [2], and in
essential oils of Monarda fistulosa or wild bergamot [3]. All
these plants are known for their traditional therapeutic value
in diseases of the gastrointestinal tract and airways. Black
cumin is used in colic, cough, asthma, and bronchitis [4];
savory is known for its spasmolytic, antidiarrheal, anticolic,
and expectorant potential [4], while wild bergamot is useful
in gut disorders, cough, and bronchitis [4]. As TQ is a known
constituent of these medicinal plants, it is worthwhile to
investigate the pharmacology of this compound.
TQ has been reported for its therapeutic potential in a
number of medical conditions. Most notably, it is regarded

as a potent antioxidant [5, 6] as well as known for its
analgesic and antiinflammatory [7], nephroprotective [8],
hepatoprotective [5, 6], neuroprotective [9], and anticancer
[10] properties. To further explore the pharmacology of this
therapeutically active compound, we tested it on diﬀerent
standard isolated smooth and cardiac muscle preparations.
We found that TQ exhibits gut spasmolytic, tracheal, and
airway relaxant (looking at Ca++ signalling in airway smooth
muscle cells, or ASMC, using fluo-4-loaded mouse lung
slices), vasodilator and relaxant activities on the cardiac
muscles mediated most possibly, at least in part, via blockade
of Ca++ influx into the cells through voltage-operated Ca++
channels (VOCC).

2. Methods
2.1. Animals. Experiments performed complied with the
rulings of the Institute of Laboratory Animal Resources,
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Figure 1: Chemical structure of thymoquinone (C10 H12 O2 ; molecular weight 164.20).

Commission on Life Sciences, National Research Council
and were approved by the Ethics Review Committee of
the Aga Khan University and Research Ethics Boards of
McMaster University and St. Joseph’s Hospital. Experiments
were done using local rabbits (∼1 kg; either sex), guinea
pigs (500–600 g; either sex), Sprague-Dawley rats (170–200 g;
male), and Balb-C mice (6–8 months old; female). These
were housed in animal quarters at Aga Khan University
(rabbits, guinea pigs, and rats) and St. Joseph’s Hospital
(mice) in environmentally controlled (23–25◦ C) and specific
pathogen-free conditions. The animals were given a standard
chow ad libitum and allowed free access to tap water.
2.2. Drugs and Reagents. TQ, the subject of this study,
was obtained from the Sigma Chemical Company (St.
Louis, MO, USA). The following reference chemicals were
obtained from the source specified: acetylcholine chloride (ACh), atropine sulphate, carbamylcholine chloride
(carbachol, CCh), isoprenaline hydrochloride, Nω -nitro-Larginine methyl ester hydrochloride (L-NAME), phenylephrine hydrochloride (PE), propranolol hydrochloride, and
verapamil hydrochloride (Sigma Chemical Company). The
following chemicals were used to make physiological salt
solutions: potassium chloride (Sigma Chemical Company),
calcium chloride, glucose, magnesium chloride, magnesium
sulphate, potassium dihydrogen phosphate, sodium bicarbonate, sodium chloride, sodium dihydrogen phosphate (E.
Merck, Darmstadt, Germany), and ethylene glycol tetraacetic
acid (EGTA) (BDH Laboratory Supplies, Poole, England). All
chemicals used were of the highest purity grade.
Cell culture reagents were obtained from Invitrogen
Life Technologies–GIBCO (Carlsbad, CA, USA). Dulbeccomodified Eagle’s medium (DMEM) for slice incubation was
supplemented with PennStrep (penicillin 10,000 units/mL,
streptomycin 10,000 μg/mL), amphotericin B (125 μg),
L-ascorbic acid 35 μg/mL, transferrin 5 μg/mL, selenium
3.25 ng/mL, and insulin 2.85 μg/mL. All reagents were
obtained from Sigma-Aldrich (St. Louis, MO, USA) unless
specified otherwise. Hanks-balanced salt solution (HBSS;
Invitrogen Inc., Burlington, ON, Canada) was supplemented
with 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
buﬀer (HEPES, 0.02 M) and was titrated to pH 7.4 with
NaOH at 37◦ C. Agarose-type VII solution (4% w/v, SigmaAldrich) was dissolved in distilled water at 60◦ C, cooled to
37◦ C, and mixed with 2X HBSS to give a 2% agarose-HBSS
solution at 37◦ C.
2.3. Isolated Rabbit Jejunum Preparation. Experiments were
performed as described earlier [11]. Segments of rabbit

jejunum (2 cm long) were suspended in 10 mL tissue baths
containing Tyrode’s solution, aerated with a mixture of 95%
oxygen and 5% carbon dioxide (carbogen), and maintained
at 37◦ C. The composition of Tyrode’s solution in mM was
2.68 KCl, 136.9 NaCl, 1.05 MgCl2 , 11.90 NaHCO3 , 0.42
NaH2 PO4 , 1.8 CaCl2 , and 5.55 glucose. Isotonic intestinal
responses were recorded using Harvard student oscillographs
and force transducers. Each tissue was allowed to equilibrate
for at least 30 min before the addition of drugs. Under these
conditions, rabbit jejunum exhibits spontaneous rhythmic
contractions, allowing testing of relaxant (spasmolytic)
activity directly without the use of an agonist. Any potential
contractile eﬀect of test material was assessed as percent of
maximum eﬀect produced by control drug, ACh (10 μM),
while inhibitory eﬀect was measured as percent change
in spontaneous contractions of rabbit jejunum obtained
immediately before the addition of the test compound.
2.4. Determination of Ca++ Antagonist Activity in Isolated
Rabbit Jejunum. To assess whether the spasmolytic activity
of test compound was mediated through Ca++ channel
blockade, high K+ (80 mM) concentration was used to
depolarize the rabbit jejunum preparations as described by
Farre et al. [12]. High K+ was added to the tissue bath, which
produced a sustained contraction in the muscle preparation.
Test compound was then added to the tissue bath in a
cumulative fashion to obtain a concentration-dependent
inhibitory response [13]. The relaxation of jejunum preparation precontracted with high K+ was expressed as percent
of the control response mediated by high K+ . To possibly
confirm this Ca++ antagonist activity of the test compound,
tissue was allowed to stabilize in normal Tyrode’s solution,
which was then replaced with Ca++ -free Tyrode’s solution
containing EGTA (0.1 mM) for 30 min in order to remove
all Ca++ from the tissue. This solution was further replaced
with a K+ -rich and Ca++ -free Tyrode’s solution, having the
following composition: KCl 50, NaCl 91.04, MgCl2 1.05,
NaHCO3 11.90, NaH2 PO4 0.42, glucose 5.55, and EGTA
0.1 mM. Following an incubation period of 30 min, control
concentration-response curves (CRCs) of Ca++ , added into
the tissue bath, were constructed. When the control CRCs of
Ca++ were found super imposable (usually after two cycles),
the tissue was pretreated with the test compound for 60 min
to confirm the possible Ca++ channel blocking eﬀect. The
CRCs of Ca++ were then reconstructed in the presence of
increasing concentrations of the test compound. Verapamil
was used as a positive control.
2.5. Isolated Guinea-Pig Ileum Preparation. Guinea-pig
ileum segments 2 cm long were mounted in 10 mL tissue
baths containing Tyrode’s solution, aerated with carbogen,
and maintained at 37◦ C. Isotonic responses were recorded
on Harvard student oscillographs. Under these conditions,
ileum behaves as a quiescent preparation and helps in evaluation of substances with contractile activity. A preload of
1 g was applied to each tissue and kept constant throughout
the experiment. Following an equilibration period of 30 min,
isotonic contractions to ACh (0.3 μM) were repeated to
stabilize the preparation. An agonist contact time of 20 sec
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was used, together with a 3 min interval between doses.
Sustained contractions, with high K+ (80 mM), were also
induced to test for possible relaxant activity.
2.6. Isolated Guinea-Pig Trachea Preparation. Guinea-pig
tracheal tubes were dissected out and kept in Kreb’s solution
with composition (mM) of NaCl 118.2, NaHCO3 25.0, CaCl2
2.5, KCl 4.7, KH2 PO4 1.3, MgSO4 1.2, and glucose 11.7; pH
7.4. Tracheal tube was cut into rings, 2-3 mm wide, each
containing 2 cartilage rings. Each tracheal ring was opened
by a longitudinal cut on the ventral side opposite to the
smooth muscle layer, forming a tracheal strip with a central
part of smooth muscle in between the cartilaginous portions
on the edges [14]. The preparation was then mounted in
a 20 mL tissue bath containing Kreb’s solution maintained
at 37◦ C and aerated with carbogen gas. A preload tension
of 1 g was applied to each of the tracheal strips. The tissue
was equilibrated for 1 hr, after which contractile responses
to submaximal concentrations of CCh (1 μM), intervals of
45 min, were recorded until reproducible responses were
obtained. We then tested the eﬀect of the test compound on
resting baseline tension of the tracheal strip as well as against
CCh (1 μM) and high K+ -(80 mM) induced contractions.
To test for an involvement of β-adrenergic receptors in
the relaxant eﬀect of the test compound, the tissues were
pretreated for 1 hr with propranolol (1 μM), and response of
test compound was repeated in the presence of the antagonist
upon CCh-induced contractions.
2.7. Airway Contractility and [Ca++ ]i in Mouse Lung Slices:
Preparation of Slices. Lung slices were prepared as previously
described in mice [15, 16]. Mice were euthanized by CO2 followed by terminal exsanguination. The trachea was exposed
and cannulated using a blunt-ended 19 G needle, followed
by chest wall removal to expose the lungs. The lungs were
inflated with approximately 1.2 mL agarose (2% in HBSS;
37◦ C). To clear the airway lumen, 0.2 mL of air was injected
to flush the agarose-HBSS solution out of the airways into the
alveolar tissue. The lungs were rinsed with 4◦ C 1X HBSS and
the whole mouse was kept at 4◦ C for 15 minutes. The lungs
were then removed and placed in 4◦ C HBSS for an additional
30 minutes to ensure the complete gelling of the agarose
within the lungs. The lungs were separated into individual
lobes and bathed in cold HBSS. Slices (approximately 120 μm
thick) were cut in 4◦ C HBSS with an EMS-4000 Tissue Slicer
(Electron Microscopy Sciences, Hatfield, PA, USA) from the
right upper lobe, transferred to room temperature HBSS
until all slices were obtained from the lobe, then transferred
to DMEM, and incubated overnight at 37◦ C.
2.8. Airway Contractility and [Ca++ ]i in Mouse Lung Slices:
Ca++ Fluorimetry. Experiments were performed as described
previously [16]. Lung slices were selected for study only
if: (a) the airway of interest was free of agarose, (b)
beating of cilia was observed, and (c) the epithelium of
the airway was intact. In each group of experiments, slices
from diﬀerent mice were used. For use in confocal laserscanning microscope, the slices were loaded for 1 h at 37◦ C
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with the Ca++ -sensitive fluorescent probe, fluo-4 AM (7 μM;
Molecular Probes, Eugene, OR, USA) dissolved in dimethyl
sulphoxide with 0.01% pluronic F-127 added to enhance
solubility [17]. The slices were then mounted between two
glass cover slips, held in position by a piece of a nylon
mesh (CMN-300-B, Small Parts, Miami Lakes, FL, USA), and
placed on the stage of a custom-built confocal microscope
equipped with a 20X objective. The bathing solution for all
experiments was carbogen-aerated 1X HBSS at 37◦ C which
was exchanged constantly via superfusion throughout the
experiment. Tissues were washed with 1X HBSS for 30 min
prior to the start of experiment to remove extracellular fluo4 AM.
2.9. Airway Contractility and [Ca++ ]i in Mouse Lung
Slices: Image Acquisition. The tissues were illuminated using
488 nm light from a 20 mW photodiode laser (Coherent
Technologies, Palestine, TX, USA), and two distinct images
were collected simultaneously: one comprised the light
emitted by the dye (only wavelengths greater than 500
nm, using a long-pass filter) to indicate the changes in
intracellular Ca++ concentration ([Ca++ ]i ) within individual
cells (giving the fluorescent image), as well as the 488 nm
transmitted laser light passing through the tissue to provide
structural details of the whole tissue (giving the laser image).
Images were formed and visualized on a computer screen as
emitted (fluorescent) and transmitted (laser) images using
the recording software Video Savant (IO Industries Inc.,
London, ON, Canada). Changes in airway diameter (average
diameter range is 145–235 μm) were determined by drawing
a straight line across the airway in the transmitted image,
and a line scan was performed to obtain change in diameter
at that particular position. Exposure of the tissue to the
laser light during the experiment was limited to the image
collection period using a computer-controlled shutter to
minimize photobleaching. Frames were captured in timelapse at a rate of one frame per second and were stored as
TIF stacks of several hundred frames. The digitized images
for each time point following stimulation were analyzed by
selecting regions of interest of 10 × 10 pixels for measurement
of [Ca++ ]i , while cell pixel intensities were analyzed frame
by frame using custom-written macros in the image analysis
software Scion (Scion Corporation, Frederick, MD, USA).
Fluorescence intensities were saved and plotted against time
in SigmaPlot (Systat Software Inc., Point Richmond, CA,
USA). An increase in fluorescence intensity was interpreted
as an increase in [Ca++ ]i . Autofluorescence was evaluated in
nonloaded preparations and was found to be less than 5% of
the fluorescence of fluo-4-loaded tissues.
After the tissue was superfused with HBSS for 30 min,
baseline [Ca++ ]i images were recorded. Later, ACh (10−5 M)
was added in the perfusion chamber and superfused over
the lung slice preparation for around 2 min to record the
eﬀect of ACh on airway diameter and Ca++ handling (change
in [Ca++ ]i ) in ASMC. The eﬀect of vehicle control, alone,
on airway diameter and average fluorescence intensity (AFI)
were also determined as was the eﬀect of test substance,
alone, on baseline airway diameter and AFI. The slice was
then washed and superfused with HBSS, after which it was
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incubated with TQ for 40 min in order to test for its eﬀect
on the ACh-induced change in [Ca++ ]i and airway diameter.
Later, the ACh response was repeated in presence of TQ.
Additionally, to rule out any reduction in the response of
ACh due to receptor desensitization, the eﬀect of ACh was
repeated, after 30 min, in the presence of only the vehicle.
After recording these responses on whole airway, we were
able to review the video recordings and focus on single
ASMC surrounding the airways which had earlier been
shown to respond to ACh: in this way the response of ACh,
alone or in the presence of the blockers, could be analyzed at
the level of single ASMC.
2.10. Isolated Endothelium-Intact and Endothelium-Denuded
Rat Aorta Preparation. The procedure of Furchgott and
Zawadzki [18] was followed with some modifications. Care
was observed in isolating the thoracic rat aorta to avoid any
damage to endothelium. Rings, 3 mm wide, were mounted
in 5 mL tissue baths with Kreb’s solution at 37◦ C and
aerated with carbogen gas. A preload of 1 g was applied
to the tissue preparations and were allowed to incubate
for 30 min. Changes in tension were recorded via World
Precision Instrument’s (WPI) isometric force transducers
(Fort 100) connected to Transbridge 4M and displayed on
to a personal computer via CVMS Data Acquisition System.
Following an equilibration period of 30 min, the tissues were
stabilized with repeated concentrations of PE (1 μM). After
stabilization, an induced contraction was obtained with PE
(1 μM). Once a plateau was achieved, ACh (0.1 μM) was
administered upon this PE-induced contraction to confirm
endothelium-dependent relaxation. The endothelium lining
of the tissues was removed by gentle rubbing, which resulted
in the disappearance of this relaxation. To study a potential
vasodilator eﬀect of the test compound, the following
strategies were followed.
(1) Determine the vasodilator eﬀect of test compound
in endothelium-intact preparations upon PE-(1 μM)
and high K+ -(80 mM) induced contractions.
(2) Test the vasodilator eﬀect of compound in L-NAME
(0.1 mM; for 60 min) and atropine (1 μM; for 20 min)
pretreated PE-(1 μM) contracted endothelium-intact
preparations.
(3) Determine vasodilator eﬀect of test compound; this
time on endothelium-denuded preparations upon
PE-(1 μM) induced contractions.
2.11. Isolated Guinea-Pig Atria Preparation. Experiments
were carried out as previously described [19]. Isolated right
and left atria from guinea pigs were mounted separately in
20 mL tissue baths containing Kreb’s solution maintained
at 32◦ C (unsteady recording at temperature >32◦ C) and
aerated with carbogen gas. The tissues were allowed to beat
spontaneously under the resting tension of 1 g. An equilibrium period of 30 min was given before the application
of any drug. Control responses of ACh (0.1–0.3 μM) and
isoprenaline (0.1 μM) were obtained at least in duplicate.
Tension changes in the tissue were recorded via a Grass

force-displacement transducer (model FT-03) using Grass
Polygraph (model 7). After looking at a possible response
of the pure compound in this tissue, this response would
be challenged in the presence of atropine 1 μM (20 min) in
order to determine involvement of muscarinic receptors in
the mode of action.
2.12. Data Analysis. All the data are expressed as mean
standard error of mean (SEM, n = number of experiment)
and the half maximal eﬀective concentration (EC50 ) with
95% confidence intervals (CIs). Statistical comparisons were
made using one-way analysis of variance (ANOVA) followed
by Tukey’s Multiple Comparison test or two-way ANOVA
as appropriate, with P < 0.05 noted as being statistically
significant (GraphPad program, GraphPad, San Diego, CA,
USA).

3. Results
3.1. Eﬀect on Isolated Rabbit Jejunum. When tested on the
spontaneous contractions of rabbit jejunum, TQ was found
to be devoid of any stimulant eﬀect and instead caused a
concentration-dependent (100–1000 μM) spasmolytic eﬀect
(Figure 2(a)), with an EC50 of 156.9 μM (95% CI 137.6–
178.9; n = 5). To further look into this relaxant eﬀect,
the response of the compound was tested on high K+ (80 mM) induced contractions. TQ exhibited concentrationdependent (100–3000 μM) relaxation of K+ -induced contractions (Figure 2(b)) with an EC50 value of 400.7 μM (95%
CI 243.2–659.9; n = 5). This potential interaction with Ca++
channels was further studied in jejunum. TQ concentration
dependently (200–500 μM; n = 4) shifted the Ca++ CRCs to
the right (Figure 3(a)), similar to that produced by verapamil
(0.3–1.0 μM; n = 3; Figure 3(b)).
3.2. Eﬀect on Isolated Guinea-Pig Ileum. TQ tested on the
resting baseline tension of guinea-pig ileum did not show
any eﬀect up to 1000 μM, thus ruling out the possibility of a
stimulant eﬀect of this compound on this tissue preparation.
To see if TQ had a relaxant eﬀect, similar to one seen in rabbit
jejunum preparation, sustained contractions were induced
with high K+ (80 mM), allowing acquisition of inhibitory
concentration-response data for TQ. The cumulative addition of TQ, to tissue bath, relaxed the high K+ -induced
contractions in guinea-pig ileum (Figure 2(b)) from 50–
1000 μM with EC50 value of 272.4 μM (95% CI 183.8–403.7;
n = 3).
3.3. Eﬀect on Isolated Guinea-Pig Trachea. TQ was first tested
on the resting baseline of the tissue. It was found to be devoid
of any eﬀect up to the dose of 1000 μM (not shown; n = 3).
Later, when tested on high K+ -(80 mM) and CCh-(1 μM)induced contractions, TQ concentration dependently (30–
1000 μM) inhibited these contractions (Figure 4(a)) with
EC50 values of 270.1 μM (95% CI 184.0–396.5; n = 3) and
295.3 μM (95% CI 254.4–342.7; n = 5), respectively, showing
no selectivity against any of the agonists (Figure 4(b),
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Figure 2: Tracing showing spasmolytic eﬀect of thymoquinone on spontaneously contracting isolated rabbit jejunum preparation (a). (b)
shows pooled data for the inhibitory eﬀect of thymoquinone on sustained contractions induced by high K+ (80 mM) in isolated rabbit
jejunum and guinea-pig ileum preparations. Values shown are mean ± SEM, n = 3–5; there is significant diﬀerence between both the curves
(P < 0.001) and between individual concentrations in each curve (P < 0.0001), two-way ANOVA.
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Figure 3: Curves showing the concentration-dependent inhibitory eﬀect of thymoquinone (a) and verapamil (b) on Ca++ concentrationresponse curves, constructed in a Ca++ -free medium in isolated rabbit jejunum preparations. Values shown are mean ± SEM, n = 3-4; there is
significant diﬀerence between all the curves in (a) and (b) (P < 0.0001) and between individual concentrations in all the curves (P < 0.0001),
two-way ANOVA.
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P > 0.05). This relaxant eﬀect of TQ, when tested on CChinduced contraction, was found to be resistant to blockade
by propranolol (1 μM) (Figure 4(b)).
3.4. Mouse Lung Slice Preparation: Eﬀect on Airway Contractility. ACh (10 μM) produced a marked contraction of mouse
airways in the lung slice preparation, seen as reduction in
individual airway diameter (Figures 5(a) and 6(a)). The
contraction was fast, reproducible, and the airways returned
to the baseline diameters once the agonist was washed oﬀ.
TQ, when given alone (up till 1000 μM) to the lung slice
preparations, did not exhibit any eﬀect on resting airway
contractility/diameter. When a lung slice was pretreated for
40 min in presence of increasing concentrations of TQ (10–
100 μM), a reduction in ACh-induced airway contraction
was observed. Figure 6(b) shows the eﬀect of TQ (100 μM)
on ACh-induced airway contraction in one lung slice, while
Figure 6(c) shows the pooled data for the eﬀect of 10 and
100 M TQ. The % reduction in airway diameter seen with
ACh, in presence of TQ 10 and 100 μM, was 73.5 ± 4.8%
(n = 6; P < 0.01; % of ACh control) and 33.5 ± 8.0% (n = 5;
P < 0.001; % of ACh control), respectively (Figure 6(c)).
Verapamil, in concentration of 1 and 10 μM, only marginally
attenuated the airway contractile eﬀect produced by ACh
(Figure 6(c)). In the presence of verapamil 1 and 10 μM, ACh
reduced the airway diameter to 82.7 ± 1.0% (n = 4; % of
ACh control) and 77.5 ± 1.7% (n = 4; P < 0.05; % of ACh
control), respectively.
3.5. Mouse Lung Slice Preparation: Eﬀect on [Ca++ ]i in
ASMC. In addition to airway contraction, ACh (compared
to baseline values) also resulted in elevation of AFI, an
indicator of increased [Ca++ ]i in ASMC (Figures 5(b) and
7(a)). TQ, in concentrations of 10 and 100 μM, did not
aﬀect the baseline AFI but suppressed the ACh-induced Ca++
transients and oscillations (shown as reduced fluorescence
in line scan of an ASMC and inhibited ACh-induced AFI
increase in line graph, Figure 7(b)). The ACh-induced
increase in AFI, in the presence 10 and 100 μM TQ, was 61.1
± 3.4 (n = 6, P < 0.001, % of ACh response) and 26.7 ± 3.7
(n = 5, P < 0.001), respectively. Pooled data showing the %
increase in fluorescence by ACh alone, and in the presence
of increasing concentrations of TQ, is given in Figure 7(c).
Verapamil in concentrations of 1 μM and 10 μM, similar to
TQ, inhibited ACh-induced elevation of AFI (Figure 7(c)) to
87.7 ± 1.1 (n = 4; % of ACh control) and 29.1 ± 2.1 (n = 4;
P < 0.001, % of ACh control), respectively.
3.6. Eﬀect on Isolated Rat Aorta. TQ was devoid of any activity on resting baseline tension of the tissue up to the highest
concentration tested (1000 μM) (not shown). When tested
against PE-(1 μM) induced contractions, TQ concentration
dependently (300–3000 μM) relaxed the agonist-induced
contractions (Figure 8) with an EC50 value of 406.2 μM (95%
CI 310.6–531.2; n = 5). The tissue was later pretreated
with L-NAME, and TQ was retested. TQ again relaxed
the preparation (300–3000 μM) at similar concentrations
(Figure 8). There was no significant diﬀerence between
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the concentration-response curves of TQ in the absence
or presence of L-NAME (P > 0.05). Additionally, neither
pretreatment of tissues with atropine (1 μM) (Figure 8), nor
denuding the tissues of endothelium (data not shown), had
any change on potency or eﬃcacy of vasodilator activity of
TQ.
When TQ was tested upon high K+ -(80 mM) induced
contractions, a concentration-dependent relaxation (300–
3000 μM) was observed (Figure 8) with an EC50 value of
290.1 μM (95% CI 255.3–329.8; n = 4). The vasodilator
eﬀect of TQ on high K+ -induced contractions was exhibited
at concentrations significantly lower than those for PEinduced contractions (P < 0.05; see Figure 8).
3.7. Eﬀect on Isolated Guinea-Pig Atria. TQ exhibited a concentration-dependent relaxation of the force (50–1000 μM)
and rate (50–2000 μM) of atrial contractions (Figure 9(a))
with EC50 values of 609.1 μM (95% CI 212.1–1749.0; n = 5)
and 246.4 μM (95% CI 140.6–432.0; n = 4), respectively.
There was no significant diﬀerence (P > 0.05) between the
relaxant eﬀect of TQ on the force or rate of atrial contractions
(Figure 9(b)). The relaxant eﬀect of the compound was
resistant to blockade by atropine (1 μM) (data not shown).

4. Discussion
TQ showed a concentration-dependent inhibitory eﬀect on
the spontaneously beating jejunal preparation indicating
intestinal smooth muscle relaxant activity. The spontaneous
contractions of smooth muscles, including that of rabbit
jejunum, are dependent upon an increase in the cytoplasmic
free Ca++ , which activates the contractile elements [20].
In order to investigate the possible mechanism of this
relaxant action, sustained contractions were obtained with
high K+ (80 mM) which involves entry of Ca++ into the cells
through VOCC [21]. The compound, when tested on high
K+ -induced contractions, caused a concentration-dependent
relaxation possibly indicating restricted entry of Ca++ via
VOCC, thus showing a Ca++ antagonistic eﬀect [20]. To
further look into this mechanism, rabbit jejunum tissues and
the surrounding media were rendered Ca++ -free by use of
EGTA, a Ca++ chelator, and Ca++ CRCs were constructed
by externally administering Ca++ into the tissue baths in the
absence or presence of TQ [22]. Under these conditions,
externally administered Ca++ causes contraction of tissues
by entering via VOCC [23]. TQ shifted the Ca++ CRCs
to the right, further indicating the possible ability of the
compound to block entry of Ca++ via VOCC. This eﬀect of
TQ was similar to verapamil which is a standard intestinal
spasmolytic agent with VOCC antagonist eﬀect [24].
TQ was tested on another isolated intestinal preparation
that is of guinea-pig ileum. As expected from the results
seen in jejunum, the compound showed no contractile eﬀect
although ileum is known to be more sensitive to substances
with contractile activity [25]. When tested on high K+ induced contractions, TQ showed concentration-dependent
relaxation, similar to that seen in jejunum. Previously AlMajed et al. [26] showed that TQ-mediated relaxation
of histamine- and serotonin-contracted guinea-pig ileum
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Figure 4: Typical tracing showing the relaxant eﬀect of thymoquinone on high
and carbachol- (CCh, 1 μM) induced
contractions in isolated rabbit trachea preparation (a); upper tracing provides a time control. Pooled data for this relaxant eﬀect of the
compound on high K+ -(80 mM) and carbachol-(CCh, 1 μM) induced contractions is shown in (b). Also shown in (b) is the eﬀect of
thymoquinone in the absence and presence of propranolol-(1 μM) on CCh-(1 μM) induced contractions. Values shown are mean ± SEM,
n = 3–5; there is no diﬀerence between the curves (P > 0.05), but there is a significant diﬀerence between individual concentrations in all the
curves (P < 0.0001), two-way ANOVA.
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Figure 5: Airway contractile eﬀect of acetylcholine (ACh). Images showing the progressive airway contractile eﬀect of ACh (from left to
right), shown in a series of (a) transmitted light (upper panel) and (b) fluorescent (lower panel) images. Note the decrease in the size
of airway lumen (AL) in response to ACh administration in the upper panel. White arrows show appearance of bright fluorescent bands
(airway smooth muscles) around the airway after ACh administration. Last column shows that the airway diameter and brightness (Ca++
levels) return to the baseline after washing the lung slice with physiological salt solution. Time course for the eﬀect of ACh on airway
contraction to washout is 2 min.
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Figure 6: Inhibitory eﬀect of thymoquinone (TQ) on acetylcholine-(ACh, 10 μM) induced reduction in airway diameter in mouse lung
slices. (a) and (b) show the eﬀect of ACh, alone (top, a) and in presence (b) of TQ (100 μM), on airway diameter shown as a line scan of a
single lung airway. Subfigure (c) shows pooled data for the contractile eﬀect of ACh on airway diameter in the absence (control) and presence
of TQ 10 μM (n = 6), TQ 100 μM (n = 5), verapamil 1 μM (Verap; n = 4), and verapamil 10 μM (Verap; n = 4). Values shown are mean ±
SEM; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, and # P > 0.05; one-way ANOVA followed by Tukey’s Multiple Comparison test.

was through a combination of pathways: (1) inhibition of
lipoxygenase products of arachidonic acid metabolism and
(2) through an undisclosed nonspecific mechanism. By the
help of results obtained in our study in intestinal jejunal
and ileal tissues, we can now possibly indicate that the
nonspecific mechanism for TQ action could be through
blockade of VOCC. For the gastrointestinal tract, TQ has
been reported to have gastroprotective activity particularly
in colitis [27] and gastric mucosal injury [28]. Our results
showing spasmolytic activity of TQ might also explain the
beneficial eﬀects of TQ-containing medicinal plants such as
black cumin, savory and wild bergamot in hyperactive states
of gut.
For determining the activity of TQ in respiratory tissues,
it was initially tested on isolated guinea-pig trachea and
then later in fluorescence dye-loaded mouse lung slices.
While TQ was devoid of any contractile eﬀect on baseline
tone in the isolated tracheal preparation, its concentrationdependently suppressed diﬀerent agonist-induced contractions. TQ relaxed the induced contractions of high K+
and CCh at similar potency. The tracheal relaxant eﬀect

was resistant to blockade by propranolol, a nonspecific βadrenergic blocker [29] thus ruling out such a mechanism
in its eﬀect.
To further look into the airway relaxant eﬀect of TQ
and its relationship with Ca++ signalling, we screened the
compound on fluorescence-dye-(fluo-4-) loaded mouse lung
slices and were able to focus on the eﬀect of TQ on Ca++
handling and whole airway contraction in ASMC. ACh
produced an increase in AFI which consisted of a sharp rise
in [Ca++ ]i (Ca++ transient, needed to establish the airway
tension at time of airway contraction), followed by a drop
in this level and then a sustained plateau with multiple
Ca++ oscillations (needed to maintain the tension during
airway contraction). These ACh-induced Ca++ transients and
oscillations, in ASMC have been reported in the literature
previously [15, 30]. TQ, in increasing concentrations, inhibited both ACh-induced Ca++ transients and oscillations thus
indicating that it might be interfering with Ca++ signalling
in airways. In murine ASMC, an ACh-induced increase in
[Ca++ ]i is known to be caused: (1) indirectly through influx
of extracellular Ca++ through Ca++ channels on plasma
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Figure 7: Inhibitory eﬀect of thymoquinone (TQ) on acetylcholine-(ACh, 10 μM) induced elevation of average fluorescence intensity (AFI),
representing intracellular Ca++ ion concentrations ([Ca++ ]i ), in airway smooth muscle cells (ASMC) studied via fluo-4-loaded mouse lung
slices. (a) shows eﬀect of ACh, alone, while (b) shows eﬀect of ACh in presence of TQ (100 μM), on AFI shown as a line graph of the change
in AFI and as a line scan of a single ASMC. Subfigure (c) shows pooled data for the eﬀect of ACh on AFI in the absence (control) and presence
of TQ (10 μM; n = 6), TQ (100 μM; n = 5), verapamil (Verap; 1 μM; n = 4), and verapamil (Verap; 10 μM; n = 4). Values shown are mean ±
SEM; ∗∗∗ P < 0.001, one-way ANOVA followed by Tukey’s Multiple Comparison test.
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Figure 8: Graph showing concentration-dependent relaxant eﬀect
of thymoquinone on high K+ -(80 mM) and phenylephrine-(PE,
1 μM) induced contractions in isolated endothelium-intact rat
aorta. Graph also shows vasodilator eﬀect of thymoquinone in the
absence and presence of atropine (1 μM) and L-NAME (0.1 mM) on
PE-(1 μM) induced contractions. Values shown are mean ± SEM,
n = 4-5; there is a significant diﬀerence between the two curves
with “bold symbols” (P < 0.05), while no diﬀerence between all the
three PE curves (P > 0.05). There is a significant diﬀerence between
individual concentrations in all the curves (P < 0.0001), two-way
ANOVA.

membrane and (2) directly through release of Ca++ from the
intracellular Ca++ stores [15]. This means that TQ is possibly
interfering with either/both of these mechanisms to inhibit
the ACh-induced increase in [Ca++ ]i . Verapamil, a standard
VOCC antagonist, also inhibited the ACh-induced increase
in [Ca++ ]i possibly via its ability to stop Ca++ influx into
the cells and thus halt the refilling of internal Ca++ stores.
VOCC antagonists also abolish high K+ -induced increase
in [Ca++ ]i in mouse ASMC [30]. On airway contraction,
ACh showed a profound contractile eﬀect. This contractile
eﬀect of ACh was inhibited by increasing concentrations
of TQ but, interestingly, not by verapamil. Unlike TQ,
verapamil only marginally inhibited the ACh-induced airway
contraction, and there was no significant diﬀerence between
the eﬀects of two increasing concentrations of verapamil
on the ACh-induced airway contraction (P > 0.05). Thus,
TQ showed a similar eﬀect to verapamil on ACh-induced
increase in Ca++ transients and oscillations but not the
cholinergic mechanical response. This shows a diﬀerence in
the modes of action of TQ and verapamil in the mouse
AMSC. Perez and Sanderson [30] have shown that high
concentrations of K+ , which enhance inward movement of
Ca++ through opening of VOCC in mouse ASMC, elicit

changes in AFI but hardly show any significant change in
mouse airway constriction. This could be a reason as to
why in our results, verapamil did inhibit the ACh-induced
increase in AFI but not the ACh-induced airway contraction.
This also reiterates the fact why blockers of VOCC are hardly
used clinically in asthma. On the contrary, TQ showed an
inhibitory eﬀect, unlike that of verapamil that was able
to significantly inhibit Ca++ transients and oscillation and
airway contraction. This airway relaxant eﬀect of TQ also
explains the traditional use of its parent medicinal plants like
black cumin, savory and wild bergamot in hyperactive states
of respiratory system like cough and asthma. Some previous
studies [26, 31] have shown a tracheal relaxant eﬀect of TQ.
Without specifying, these studies had indicated presence of
an additional mechanism. We have successfully shown that
TQ not only interferes with Ca++ signalling pathways but
also inhibits airway contraction. TQ has also been shown
to have an antiinflammatory action [32, 33] and therapeutic
eﬀect in animal models of asthma [34, 35]. The tracheal and
airway relaxant eﬀect of TQ in this study, together with its
reported antiinflammatory actions, indicates its benefit in
asthma therapy. Asthma is a chronic disease characterized by
inflammation and hypersensitivity of airway smooth muscles
to diﬀerent spasmogens [36].
TQ was also tested on cardiovascular preparations of rat
aorta and guinea-pig atria. Rat aorta was used to examine the
eﬀect of TQ on vascular resistance. Rat aorta is a standard
tissue used for determining endothelium-dependent and independent vasodilation [37]. TQ was found devoid of any
vasoconstrictor eﬀect on vascular baseline tone, but when
tested on the endothelium-intact rat aorta precontracted
with PE or high K+ , it inhibited sustained contractions
induced by both the agonists indicating that TQ is blocking
both the Ca++ influx pathways. TQ was more potent in
relaxing high K+ than PE-induced contractions, indicating
preference for VOCC than receptor-operated Ca++ channels
(ROCC) [38]. PE induces Ca++ influx via ROCC, while
high K+ induces Ca++ influx via VOCC [39]. The vascular
endothelium plays a pivotal role in modulating the contractility of vascular smooth muscle through the release of
vasodilator and constrictor factors [40]. One such vasodilator factor is nitric oxide (NO), while the muscarinic M3
receptors are one set of receptors through the activation of
which NO is released [18]. To observe any possible nitrergic
and/or muscarinic involvement in the vasodilator eﬀect of
TQ, tissues were separately preincubated with L-NAME, a
standard nitric oxide synthase inhibitor [41], and atropine, a
muscarinic receptor blocker [42]. This resulted in no change
in the vasodilator eﬀect of TQ indicating absence of such
mechanisms in TQ’s vasodilator eﬀect. An endotheliumindependent involvement in TQ’s vasodilator eﬀect was
further confirmed when denuding the aorta preparation of
endothelium also did not make any diﬀerence in the vascular
relaxant eﬀect of TQ (data not shown). Thus, this points to
the presence of possibly only a Ca++ antagonistic mode of
eﬀect as evident from the ability of TQ to relax the high K+ induced contractions at lower concentrations, compared to
PE. A similar vasorelaxant eﬀect of TQ, but in isolated rat
pulmonary arterial rings, was recently reported by Suddek
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Figure 9: Typical tracing showing the concentration-dependent relaxant eﬀect of thymoquinone on force and rate of spontaneous
contractions in isolated guinea-pig atrium (a). Pooled data for this negative inotropic and chronotropic eﬀect of the compound is shown in
(b). Values shown are mean ± SEM, n = 4-5; there is no diﬀerence between the curves (P > 0.05), but there is a significant diﬀerence between
individual concentrations in both the curves (P < 0.0001), two-way ANOVA.

[43] who also showed a nonnitrergic/nonmuscarinic relaxant
eﬀect of TQ. Suddek [43] concluded that TQ exhibits a
nonspecific vasorelaxant eﬀect as evident by its inhibitory
eﬀect against contractions induced by multiple agonists. We
have shown here that the nonspecific relaxant quality in TQ
might involve blockade of VOCC.
Lastly we examined the eﬀect of TQ on cardiac contractility using guinea-pig atrial preparations. TQ relaxed
the force and rate of spontaneous atrial contractions in a
concentration-dependent manner. This inhibitory eﬀect on
cardiac tissues was resistant to blockade by atropine indicating an action independent of muscarinic receptor activation.
We could not investigate the mechanism of this eﬀect any
further. Our observation of a possible cardiovascular relaxant
eﬀect of TQ adds to its already reported cardiovascular therapeutic eﬀects such as in hypertension and renal damage [44],
cyclophosphamide-induced cardiotoxicity [45], methionineinduced hyperhomocysteinemia [46], and atherosclerosis
[47].
In summary, our results show spasmolytic activity of TQ
in isolated smooth muscle preparations of gastrointestinal,
airway, and vascular smooth muscle tissues, while also
in cardiac muscle preparations. While these results are
novel and add new information to the already available
pharmacological data on this compound, they also help to
justify the use of TQ containing medicinal plants like black
cumin, savory and wild bergamot in muscular hyperactive
disorders of gastrointestinal, and airway and cardiovascular

systems. More detailed studies are in progress to further
investigate the mechanism of muscle relaxant activity of TQ.
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